0 XP   0   0   0

Dishman Carbogen Amcis Limited










Financial Health of Dishman Carbogen Amcis Limited




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Dishman Carbogen Amcis Limited
Buy, Hold or Sell?

Should you buy, hold or sell Dishman Carbogen Amcis Limited?

I guess you are interested in Dishman Carbogen Amcis Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Dishman Carbogen Amcis Limited

Let's start. I'm going to help you getting a better view of Dishman Carbogen Amcis Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Dishman Carbogen Amcis Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Dishman Carbogen Amcis Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Dishman Carbogen Amcis Limited. The closing price on 2022-12-02 was INR97.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Dishman Carbogen Amcis Limited Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Dishman Carbogen Amcis Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dishman Carbogen Amcis Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • A Net Profit Margin of -1.6% means that ₹-0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dishman Carbogen Amcis Limited:

  • The MRQ is -1.6%. The company is making a loss. -1
  • The TTM is -0.6%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-0.6%-1.0%
TTM-0.6%YOY-5.9%+5.3%
TTM-0.6%5Y3.4%-4.0%
5Y3.4%10Y5.9%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.6%-223.6%+222.0%
TTM-0.6%-281.7%+281.1%
YOY-5.9%-344.8%+338.9%
5Y3.4%-450.1%+453.5%
10Y5.9%-541.0%+546.9%
1.1.2. Return on Assets

Shows how efficient Dishman Carbogen Amcis Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • -0.1% Return on Assets means that Dishman Carbogen Amcis Limited generated ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dishman Carbogen Amcis Limited:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM0.0%-0.1%
TTM0.0%YOY-0.4%+0.3%
TTM0.0%5Y0.2%-0.3%
5Y0.2%10Y0.6%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-9.9%+9.8%
TTM0.0%-8.9%+8.9%
YOY-0.4%-9.3%+8.9%
5Y0.2%-11.7%+11.9%
10Y0.6%-12.7%+13.3%
1.1.3. Return on Equity

Shows how efficient Dishman Carbogen Amcis Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • -0.2% Return on Equity means Dishman Carbogen Amcis Limited generated ₹0.00 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dishman Carbogen Amcis Limited:

  • The MRQ is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-0.1%-0.1%
TTM-0.1%YOY-0.5%+0.5%
TTM-0.1%5Y0.3%-0.4%
5Y0.3%10Y1.3%-1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-12.0%+11.8%
TTM-0.1%-11.5%+11.4%
YOY-0.5%-10.8%+10.3%
5Y0.3%-14.2%+14.5%
10Y1.3%-15.2%+16.5%

1.2. Operating Efficiency of Dishman Carbogen Amcis Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dishman Carbogen Amcis Limited is operating .

  • Measures how much profit Dishman Carbogen Amcis Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • An Operating Margin of -0.2% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dishman Carbogen Amcis Limited:

  • The MRQ is -0.2%. The company is operating very inefficient. -2
  • The TTM is 0.2%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM0.2%-0.3%
TTM0.2%YOY2.4%-2.2%
TTM0.2%5Y8.6%-8.4%
5Y8.6%10Y12.7%-4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-207.3%+207.1%
TTM0.2%-271.0%+271.2%
YOY2.4%-325.9%+328.3%
5Y8.6%-454.0%+462.6%
10Y12.7%-537.1%+549.8%
1.2.2. Operating Ratio

Measures how efficient Dishman Carbogen Amcis Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.26 means that the operating costs are ₹0.26 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 0.263. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.821. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.263TTM0.821-0.559
TTM0.821YOY0.968-0.147
TTM0.8215Y0.886-0.064
5Y0.88610Y0.867+0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2632.871-2.608
TTM0.8213.504-2.683
YOY0.9683.604-2.636
5Y0.8865.132-4.246
10Y0.8676.371-5.504

1.3. Liquidity of Dishman Carbogen Amcis Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dishman Carbogen Amcis Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.18 means the company has ₹1.18 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 1.180. The company is just able to pay all its short-term debts.
  • The TTM is 0.943. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.180TTM0.943+0.238
TTM0.943YOY0.642+0.301
TTM0.9435Y0.683+0.259
5Y0.68310Y0.603+0.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1805.117-3.937
TTM0.9435.755-4.812
YOY0.6425.854-5.212
5Y0.6836.511-5.828
10Y0.6036.222-5.619
1.3.2. Quick Ratio

Measures if Dishman Carbogen Amcis Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • A Quick Ratio of 0.70 means the company can pay off ₹0.70 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 0.699. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.514. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.699TTM0.514+0.185
TTM0.514YOY0.412+0.101
TTM0.5145Y0.378+0.136
5Y0.37810Y0.238+0.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6994.284-3.585
TTM0.5144.664-4.150
YOY0.4124.787-4.375
5Y0.3785.218-4.840
10Y0.2385.182-4.944

1.4. Solvency of Dishman Carbogen Amcis Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dishman Carbogen Amcis Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dishman Carbogen Amcis Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37 means that Dishman Carbogen Amcis Limited assets are financed with 37.1% credit (debt) and the remaining percentage (100% - 37.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 0.371. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.352. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.352+0.019
TTM0.352YOY0.310+0.042
TTM0.3525Y0.306+0.046
5Y0.30610Y0.400-0.095
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.278+0.093
TTM0.3520.277+0.075
YOY0.3100.306+0.004
5Y0.3060.367-0.061
10Y0.4000.403-0.003
1.4.2. Debt to Equity Ratio

Measures if Dishman Carbogen Amcis Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • A Debt to Equity ratio of 58.9% means that company has ₹0.59 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 0.589. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.543. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.589TTM0.543+0.046
TTM0.543YOY0.450+0.094
TTM0.5435Y0.443+0.101
5Y0.44310Y0.745-0.303
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5890.315+0.274
TTM0.5430.317+0.226
YOY0.4500.319+0.131
5Y0.4430.403+0.040
10Y0.7450.462+0.283

2. Market Valuation of Dishman Carbogen Amcis Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dishman Carbogen Amcis Limited generates.

  • Above 15 is considered overpriced but always compare Dishman Carbogen Amcis Limited to the Biotechnology industry mean.
  • A PE ratio of -150.39 means the investor is paying ₹-150.39 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dishman Carbogen Amcis Limited:

  • The EOD is -152.649. Company is losing money. -2
  • The MRQ is -150.387. Company is losing money. -2
  • The TTM is -256.353. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-152.649MRQ-150.387-2.262
MRQ-150.387TTM-256.353+105.966
TTM-256.353YOY85.797-342.150
TTM-256.3535Y16.278-272.631
5Y16.27810Y11.234+5.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-152.649-8.986-143.663
MRQ-150.387-9.792-140.595
TTM-256.353-16.243-240.110
YOY85.797-20.876+106.673
5Y16.278-16.665+32.943
10Y11.234-14.732+25.966
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Dishman Carbogen Amcis Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Dishman Carbogen Amcis Limited:

  • The MRQ is 107.496. Seems overpriced? -1
  • The TTM is 171.346. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ107.496TTM171.346-63.850
TTM171.346YOY-128.802+300.148
TTM171.3465Y63.773+107.573
5Y63.77310Y68.295-4.521
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ107.496-0.032+107.528
TTM171.3460.004+171.342
YOY-128.8020.016-128.818
5Y63.7730.006+63.767
10Y68.2950.003+68.292

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dishman Carbogen Amcis Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.27 means the investor is paying ₹0.27 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dishman Carbogen Amcis Limited:

  • The EOD is 0.276. Very good. +2
  • The MRQ is 0.272. Very good. +2
  • The TTM is 0.415. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.276MRQ0.272+0.004
MRQ0.272TTM0.415-0.142
TTM0.415YOY0.453-0.038
TTM0.4155Y0.537-0.123
5Y0.53710Y0.304+0.233
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2761.835-1.559
MRQ0.2722.006-1.734
TTM0.4152.774-2.359
YOY0.4533.453-3.000
5Y0.5372.713-2.176
10Y0.3042.402-2.098
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dishman Carbogen Amcis Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.322-3.442+1169%-1.009+414%2.572-87%7.601-96%
Book Value Growth--0.9880.988+0%0.988+0%0.9880%0.9880%
Book Value Per Share--354.247358.010-1%365.846-3%347.703+2%232.525+52%
Book Value Per Share Growth--0.001-0.010+1177%-0.003+412%0.007-88%0.033-97%
Current Ratio--1.1800.943+25%0.642+84%0.683+73%0.603+96%
Debt To Asset Ratio--0.3710.352+5%0.310+20%0.306+21%0.400-7%
Debt To Equity Ratio--0.5890.543+8%0.450+31%0.443+33%0.745-21%
Dividend Per Share----0%-0%0.020-100%0.118-100%
Eps---0.641-0.243-62%-1.965+207%1.028-162%1.507-143%
Eps Growth---1.399-0.668-52%1.656-184%0.151-1026%0.179-883%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.016-0.006-63%-0.059+258%0.034-148%0.059-128%
Operating Margin---0.0020.002-201%0.024-107%0.086-102%0.127-101%
Operating Ratio--0.2630.821-68%0.968-73%0.886-70%0.867-70%
Pb Ratio0.276+1%0.2720.415-34%0.453-40%0.537-49%0.304-11%
Pe Ratio-152.649-2%-150.387-256.353+70%85.797-275%16.278-1024%11.234-1439%
Peg Ratio--107.496171.346-37%-128.802+220%63.773+69%68.295+57%
Price Per Share97.850+1%96.400148.913-35%165.575-42%183.023-47%102.517-6%
Price To Total Gains Ratio303.983+1%299.478130.775+129%26.334+1037%135.667+121%133.959+124%
Profit Growth---100.4912.955-3501%2.047-5009%50.330-300%73.844-236%
Quick Ratio--0.6990.514+36%0.412+69%0.378+85%0.238+194%
Return On Assets---0.0010.000-63%-0.004+228%0.002-149%0.006-118%
Return On Equity---0.002-0.001-58%-0.005+200%0.003-157%0.013-114%
Revenue Growth--0.9890.989+0%0.988+0%0.988+0%0.988+0%
Total Gains Per Share--0.322-3.442+1169%-1.009+414%2.592-88%7.719-96%
Total Gains Per Share Growth--1.000-0.599+160%0.761+31%-29.742+3074%-19.837+2084%
Usd Book Value--683140770.000690398077.500-1%708472005.000-4%678392539.500+1%455157920.385+50%
Usd Book Value Change Per Share--0.004-0.042+1169%-0.012+414%0.032-87%0.093-96%
Usd Book Value Per Share--4.3574.404-1%4.500-3%4.277+2%2.860+52%
Usd Dividend Per Share----0%-0%0.000-100%0.001-100%
Usd Eps---0.008-0.003-62%-0.024+207%0.013-162%0.019-143%
Usd Price Per Share1.204+1%1.1861.832-35%2.037-42%2.251-47%1.261-6%
Usd Profit---1236150.000-468630.000-62%-3809925.000+208%2033251.500-161%2981118.515-141%
Usd Revenue--75517080.00070283430.000+7%61687882.500+22%62686704.000+20%54596133.000+38%
Usd Total Gains Per Share--0.004-0.042+1169%-0.012+414%0.032-88%0.095-96%
 EOD+3 -2MRQTTM+16 -16YOY+22 -105Y+13 -2110Y+15 -19

3.2. Fundamental Score

Let's check the fundamental score of Dishman Carbogen Amcis Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-152.649
Price to Book Ratio (EOD)Between0-10.276
Net Profit Margin (MRQ)Greater than0-0.016
Operating Margin (MRQ)Greater than0-0.002
Quick Ratio (MRQ)Greater than10.699
Current Ratio (MRQ)Greater than11.180
Debt to Asset Ratio (MRQ)Less than10.371
Debt to Equity Ratio (MRQ)Less than10.589
Return on Equity (MRQ)Greater than0.15-0.002
Return on Assets (MRQ)Greater than0.05-0.001
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Dishman Carbogen Amcis Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.673
Ma 20Greater thanMa 50103.783
Ma 50Greater thanMa 100101.416
Ma 100Greater thanMa 200110.258
OpenGreater thanClose98.600
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in INR. All numbers in thousands.

Summary
Total Assets88,264,400
Total Liabilities32,724,500
Total Stockholder Equity55,539,900
 As reported
Total Liabilities 32,724,500
Total Stockholder Equity+ 55,539,900
Total Assets = 88,264,400

Assets

Total Assets88,264,400
Total Current Assets19,120,600
Long-term Assets19,120,600
Total Current Assets
Short-term Investments 1,645,900
Net Receivables 5,338,200
Inventory 7,492,700
Other Current Assets 2,076,700
Total Current Assets  (as reported)19,120,600
Total Current Assets  (calculated)16,553,500
+/- 2,567,100
Long-term Assets
Property Plant Equipment 29,585,800
Goodwill 35,827,500
Intangible Assets 1,106,800
Long-term Assets  (as reported)0
Long-term Assets  (calculated)66,520,100
+/- 66,520,100

Liabilities & Shareholders' Equity

Total Current Liabilities16,198,300
Long-term Liabilities-
Total Stockholder Equity55,539,900
Total Current Liabilities
Accounts payable 1,955,000
Other Current Liabilities 6,280,900
Total Current Liabilities  (as reported)16,198,300
Total Current Liabilities  (calculated)8,235,900
+/- 7,962,400
Long-term Liabilities
Long term Debt Total 12,420,300
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)12,420,300
+/- 12,420,300
Total Stockholder Equity
Common Stock313,600
Other Stockholders Equity 55,226,300
Total Stockholder Equity (as reported)55,539,900
Total Stockholder Equity (calculated)55,539,900
+/-0
Other
Cash And Equivalents2,689,800
Cash and Short Term Investments 4,335,700
Common Stock Shares Outstanding 156,783
Liabilities and Stockholders Equity 88,264,400
Net Tangible Assets 18,605,600



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
> Total Assets 
0
22,586,762
0
0
0
22,911,117
0
25,429,242
0
25,541,994
0
26,400,753
0
28,089,357
0
28,417,413
0
29,804,800
0
30,861,700
0
65,934,300
0
67,250,300
0
71,764,800
0
76,314,100
0
73,284,600
0
77,746,000
0
82,224,200
0
82,154,200
0
83,246,000
0
85,354,300
0
86,374,500
0
88,264,400
88,264,400086,374,500085,354,300083,246,000082,154,200082,224,200077,746,000073,284,600076,314,100071,764,800067,250,300065,934,300030,861,700029,804,800028,417,413028,089,357026,400,753025,541,994025,429,242022,911,11700022,586,7620
   > Total Current Assets 
0
6,238,727
0
0
0
6,733,031
0
7,733,959
0
7,604,653
0
8,984,632
0
10,135,257
0
10,176,390
0
11,017,900
0
10,628,600
0
13,330,500
0
14,623,700
0
15,461,500
0
17,106,300
0
15,535,700
0
16,546,200
0
18,049,700
0
17,038,900
0
16,626,400
0
16,657,800
18,387,200
18,387,200
0
19,120,600
19,120,600018,387,20018,387,20016,657,800016,626,400017,038,900018,049,700016,546,200015,535,700017,106,300015,461,500014,623,700013,330,500010,628,600011,017,900010,176,390010,135,25708,984,63207,604,65307,733,95906,733,0310006,238,7270
       Cash And Cash Equivalents 
0
240,409
0
0
0
171,382
0
330,594
0
307,171
0
469,345
0
243,162
0
524,336
0
561,400
0
287,600
0
586,100
0
539,700
0
655,200
0
1,646,000
0
763,200
0
959,700
0
1,219,400
0
1,409,400
0
2,435,400
0
1,604,000
0
1,102,400
0
0
001,102,40001,604,00002,435,40001,409,40001,219,4000959,7000763,20001,646,0000655,2000539,7000586,1000287,6000561,4000524,3360243,1620469,3450307,1710330,5940171,382000240,4090
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
132,000
0
132,000
0
0
0
3,603,700
0
183,400
0
1,782,300
0
1,223,200
0
1,020,900
0
471,200
0
1,414,300
0
1,347,500
0
1,851,300
0
1,876,600
0
2,942,600
0
3,871,000
0
1,645,900
1,645,90003,871,00002,942,60001,876,60001,851,30001,347,50001,414,3000471,20001,020,90001,223,20001,782,3000183,40003,603,700000132,0000132,0000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,967,000
0
3,986,100
0
5,821,800
0
5,870,400
0
4,453,000
0
4,293,900
0
6,343,900
0
4,730,500
0
4,145,700
0
3,581,400
5,208,800
5,208,800
0
5,338,200
5,338,20005,208,8005,208,8003,581,40004,145,70004,730,50006,343,90004,293,90004,453,00005,870,40005,821,80003,986,10003,967,000000000000000000000000
       Other Current Assets 
0
3,327,694
0
0
0
3,178,952
0
3,274,316
0
3,064,928
0
3,571,540
0
5,277,491
0
4,585,878
0
5,625,400
0
1,789,700
0
8,295,200
0
7,379,500
0
8,737,500
0
9,231,000
0
8,815,100
0
7,959,200
0
9,414,100
0
7,878,200
0
7,157,900
0
6,281,900
2,699,500
6,962,600
0
2,076,700
2,076,70006,962,6002,699,5006,281,90007,157,90007,878,20009,414,10007,959,20008,815,10009,231,00008,737,50007,379,50008,295,20001,789,70005,625,40004,585,87805,277,49103,571,54003,064,92803,274,31603,178,9520003,327,6940
   > Long-term Assets 
0
16,348,035
0
0
0
16,178,086
0
17,695,283
0
17,937,341
0
17,416,121
0
17,954,100
0
18,241,023
0
18,786,900
0
20,233,100
0
52,603,800
0
52,626,600
0
56,303,300
0
59,207,800
0
57,748,900
0
61,199,800
0
64,174,500
0
65,115,300
0
66,619,600
0
68,696,500
0
67,987,300
0
0
0067,987,300068,696,500066,619,600065,115,300064,174,500061,199,800057,748,900059,207,800056,303,300052,626,600052,603,800020,233,100018,786,900018,241,023017,954,100017,416,121017,937,341017,695,283016,178,08600016,348,0350
       Property Plant Equipment 
0
12,277,906
0
0
0
12,430,221
0
16,078,460
0
13,366,266
0
15,407,908
0
13,262,816
0
15,813,613
0
13,389,900
0
15,032,300
0
14,648,800
0
15,112,300
0
16,223,400
0
16,968,000
0
16,761,900
0
19,692,000
0
20,929,800
0
21,227,800
0
24,414,600
0
26,001,700
27,868,800
27,868,800
0
29,585,800
29,585,800027,868,80027,868,80026,001,700024,414,600021,227,800020,929,800019,692,000016,761,900016,968,000016,223,400015,112,300014,648,800015,032,300013,389,900015,813,613013,262,816015,407,908013,366,266016,078,460012,430,22100012,277,9060
       Goodwill 
0
122,966
0
0
0
2,083,299
0
122,954
0
2,434,037
0
122,954
0
2,313,617
0
134,811
0
2,531,800
0
2,531,800
0
34,551,300
0
34,069,000
0
35,329,500
0
36,607,400
0
34,702,900
0
34,640,700
0
36,847,100
0
36,905,500
0
35,810,100
0
36,187,600
0
36,456,800
0
35,827,500
35,827,500036,456,800036,187,600035,810,100036,905,500036,847,100034,640,700034,702,900036,607,400035,329,500034,069,000034,551,30002,531,80002,531,8000134,81102,313,6170122,95402,434,0370122,95402,083,299000122,9660
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423,600
0
391,700
0
1,036,800
0
1,843,700
0
1,476,200
0
1,345,400
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,345,40001,476,20001,843,70001,036,8000391,7000423,600000000000000000000000
       Intangible Assets 
0
2,112,718
0
0
0
188,834
0
0
0
39,886
0
0
0
251,032
0
0
0
381,900
0
160,900
0
601,200
0
682,100
0
561,200
0
546,800
0
1,209,600
0
1,193,300
0
1,293,400
0
1,341,100
0
1,566,500
0
1,683,100
0
1,150,900
0
1,106,800
1,106,80001,150,90001,683,10001,566,50001,341,10001,293,40001,193,30001,209,6000546,8000561,2000682,1000601,2000160,9000381,900000251,03200039,886000188,8340002,112,7180
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,101,800
0
2,371,500
0
3,152,400
0
3,241,900
0
2,161,100
0
2,992,600
0
4,215,600
0
4,314,500
0
4,263,800
0
4,259,800
2,192,500
2,192,500
0
2,294,500
2,294,50002,192,5002,192,5004,259,80004,263,80004,314,50004,215,60002,992,60002,161,10003,241,90003,152,40002,371,50003,101,800000000000000000000000
> Total Liabilities 
0
13,266,870
0
0
0
12,603,090
0
14,349,375
0
13,769,948
0
14,239,492
0
15,711,507
0
15,069,135
0
15,285,400
0
14,086,500
0
17,794,500
0
18,396,300
0
20,691,500
0
22,924,500
0
19,493,700
0
22,933,600
0
24,847,300
0
23,734,200
0
26,257,800
0
27,353,300
0
30,885,100
0
32,724,500
32,724,500030,885,100027,353,300026,257,800023,734,200024,847,300022,933,600019,493,700022,924,500020,691,500018,396,300017,794,500014,086,500015,285,400015,069,135015,711,507014,239,492013,769,948014,349,375012,603,09000013,266,8700
   > Total Current Liabilities 
0
6,630,884
0
0
0
6,808,841
0
8,550,601
0
8,656,725
0
9,188,856
0
11,047,859
0
9,260,366
0
9,517,000
0
9,381,700
0
9,936,700
0
9,123,800
0
11,777,100
0
13,724,300
0
11,983,000
0
14,053,500
0
15,689,300
0
14,890,100
0
12,488,000
0
13,465,600
14,197,900
14,197,900
0
16,198,300
16,198,300014,197,90014,197,90013,465,600012,488,000014,890,100015,689,300014,053,500011,983,000013,724,300011,777,10009,123,80009,936,70009,381,70009,517,00009,260,366011,047,85909,188,85608,656,72508,550,60106,808,8410006,630,8840
       Short-term Debt 
0
2,335,679
0
0
0
4,199,928
0
4,042,178
0
5,003,094
0
3,445,025
0
6,025,027
0
3,438,083
0
5,238,700
0
4,464,500
0
4,895,900
8,940,400
3,739,600
9,510,000
5,698,500
9,182,900
6,179,200
0
6,797,700
0
6,425,800
0
8,801,800
0
7,339,900
0
7,197,700
0
6,704,100
0
7,197,300
0
0
007,197,30006,704,10007,197,70007,339,90008,801,80006,425,80006,797,70006,179,2009,182,9005,698,5009,510,0003,739,6008,940,4004,895,90004,464,50005,238,70003,438,08306,025,02703,445,02505,003,09404,042,17804,199,9280002,335,6790
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,940,400
8,940,400
9,510,000
9,510,000
1,585,000
9,182,900
0
0
6,590,900
0
6,061,300
0
8,148,600
0
6,680,900
0
5,424,700
0
6,113,100
0
6,588,300
0
0
006,588,30006,113,10005,424,70006,680,90008,148,60006,061,30006,590,900009,182,9001,585,0009,510,0009,510,0008,940,4008,940,400000000000000000000000
       Accounts payable 
0
1,657,874
0
0
0
1,055,503
0
1,016,523
0
928,665
0
746,753
0
1,514,354
0
828,406
0
869,700
0
881,500
0
856,400
0
707,500
0
1,859,100
0
1,326,700
0
1,945,700
0
2,076,400
0
2,835,200
0
1,794,300
0
1,630,200
0
1,590,300
1,928,900
1,933,700
0
1,955,000
1,955,00001,933,7001,928,9001,590,30001,630,20001,794,30002,835,20002,076,40001,945,70001,326,70001,859,1000707,5000856,4000881,5000869,7000828,40601,514,3540746,7530928,66501,016,52301,055,5030001,657,8740
       Other Current Liabilities 
0
2,637,331
0
0
0
1,553,410
0
3,491,900
0
2,724,966
0
4,997,078
0
3,508,478
0
4,993,877
0
3,408,600
0
4,035,700
0
3,521,500
0
4,225,300
0
3,576,700
0
5,607,800
0
2,805,100
0
5,177,200
0
3,929,700
0
5,598,200
0
3,518,000
0
5,171,200
3,723,600
5,055,400
0
6,280,900
6,280,90005,055,4003,723,6005,171,20003,518,00005,598,20003,929,70005,177,20002,805,10005,607,80003,576,70004,225,30003,521,50004,035,70003,408,60004,993,87703,508,47804,997,07802,724,96603,491,90001,553,4100002,637,3310
   > Long-term Liabilities 
0
6,635,986
0
0
0
5,794,249
0
5,798,774
0
5,113,223
0
5,050,636
0
4,663,648
0
5,808,769
0
5,768,400
0
4,704,800
0
7,857,800
0
9,272,500
0
8,914,400
0
9,200,200
0
7,510,700
0
8,880,100
0
9,158,000
0
8,844,100
0
13,769,800
0
13,887,700
0
16,687,200
0
0
0016,687,200013,887,700013,769,80008,844,10009,158,00008,880,10007,510,70009,200,20008,914,40009,272,50007,857,80004,704,80005,768,40005,808,76904,663,64805,050,63605,113,22305,798,77405,794,2490006,635,9860
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,624,100
0
4,950,200
0
4,772,600
0
4,666,200
0
8,690,800
0
8,810,300
0
11,101,600
0
12,420,300
12,420,300011,101,60008,810,30008,690,80004,666,20004,772,60004,950,20003,624,10000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,256,600
0
3,502,000
0
3,664,500
0
4,009,600
0
3,886,600
0
3,929,800
0
4,385,400
0
4,171,900
0
5,079,000
0
5,077,400
5,585,600
5,585,600
0
4,105,900
4,105,90005,585,6005,585,6005,077,40005,079,00004,171,90004,385,40003,929,80003,886,60004,009,60003,664,50003,502,00003,256,600000000000000000000000
> Total Stockholder Equity
0
9,319,892
0
0
0
10,308,027
0
11,079,847
0
11,772,046
0
12,161,261
0
12,377,850
0
13,348,278
0
14,515,500
0
16,775,200
0
48,139,800
48,139,800
48,854,000
48,854,000
51,073,300
51,073,300
53,389,600
53,389,600
53,790,900
53,790,900
54,812,300
54,812,300
57,376,900
0
58,420,000
0
56,988,200
0
58,001,000
0
55,489,400
0
55,539,900
55,539,900055,489,400058,001,000056,988,200058,420,000057,376,90054,812,30054,812,30053,790,90053,790,90053,389,60053,389,60051,073,30051,073,30048,854,00048,854,00048,139,80048,139,800016,775,200014,515,500013,348,278012,377,850012,161,261011,772,046011,079,847010,308,0270009,319,8920
   Common Stock
0
18,400
0
0
0
161,394
0
161,394
0
161,394
0
161,394
0
161,394
0
161,394
0
161,400
0
322,800
0
0
0
322,800
0
327,800
0
322,800
0
322,800
0
322,800
0
313,800
0
313,600
0
313,600
0
313,600
313,600
313,600
0
313,600
313,6000313,600313,600313,6000313,6000313,6000313,8000322,8000322,8000322,8000327,8000322,800000322,8000161,4000161,3940161,3940161,3940161,3940161,3940161,39400018,4000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000-16,894,200000-13,628,200000-12,207,600000-10,781,300000-8,578,000000-7,285,200000-6,094,990000-4,624,103000-3,844,9530
   Capital Surplus 00000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
10,512,350
0
0
0
11,388,747
0
10,918,453
0
13,494,226
0
11,999,867
0
14,449,587
0
13,186,884
0
16,447,500
0
16,452,400
0
58,444,400
0
48,531,200
0
60,930,700
0
53,066,800
0
63,098,800
0
54,489,500
0
68,588,700
0
58,106,400
0
53,167,700
0
57,687,400
3,556,900
55,175,800
0
55,226,300
55,226,300055,175,8003,556,90057,687,400053,167,700058,106,400068,588,700054,489,500063,098,800053,066,800060,930,700048,531,200058,444,400016,452,400016,447,500013,186,884014,449,587011,999,867013,494,226010,918,453011,388,74700010,512,3500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue21,406,900
Cost of Revenue-4,474,200
Gross Profit16,932,70016,932,700
 
Operating Income (+$)
Gross Profit16,932,700
Operating Expense-16,694,900
Operating Income237,800237,800
 
Operating Expense (+$)
Research Development-
Selling General Administrative9,814,900
Selling And Marketing Expenses-
Operating Expense16,694,9009,814,900
 
Net Interest Income (+$)
Interest Income568,100
Interest Expense-568,100
Net Interest Income-568,1000
 
Pretax Income (+$)
Operating Income237,800
Net Interest Income-568,100
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-42,500518,100
EBIT - interestExpense = -42,500
-42,500
748,200
Interest Expense568,100
Earnings Before Interest and Taxes (ebit)525,600525,600
Earnings Before Interest and Taxes (ebitda)3,601,500
 
After tax Income (+$)
Income Before Tax-42,500
Tax Provision--222,600
Net Income From Continuing Ops180,100180,100
Net Income180,100
Net Income Applicable To Common Shares180,100
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses21,169,100
Total Other Income/Expenses Net-280,300568,100
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
7 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
8 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
8 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
8 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
8 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
8 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
8 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
8 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
8 hours ago

I found you a De